American Journal of Cardiology
Volume 98, Issue 11 , Pages 1429-1434 , 1 December 2006

Prevalence of Metabolic Syndrome After Acute Coronary Syndrome and Its Prognostic Significance

  • Carine Boulon, MD

      Affiliations

    • Université Victor Segalen Bordeaux 2, Bordeaux, France.
    • ,
  • Marianne Lafitte, MD

      Affiliations

    • The Centre d’Exploration de Prévention et de Traitement de l’Athérosclérose (CEPTA), Hôpital Cardiologique du Haut-Levêque, Pessac, France
    • ,
  • Vincent Richeboeuf, MD

      Affiliations

    • Université Victor Segalen Bordeaux 2, Bordeaux, France.
    • ,
  • Bertrand Paviot, MD

      Affiliations

    • Université Victor Segalen Bordeaux 2, Bordeaux, France.
    • ,
  • Vincent Pradeau, MD

      Affiliations

    • The Centre d’Exploration de Prévention et de Traitement de l’Athérosclérose (CEPTA), Hôpital Cardiologique du Haut-Levêque, Pessac, France
    • ,
  • Pierre Coste, MD

      Affiliations

    • Université Victor Segalen Bordeaux 2, Bordeaux, France.
    • ,
  • Jacques Bonnet, MD

      Affiliations

    • Université Victor Segalen Bordeaux 2, Bordeaux, France.
    • ,
  • Thierry Couffinhal, MD, PhD

      Affiliations

    • Université Victor Segalen Bordeaux 2, Bordeaux, France.
    • Corresponding Author InformationCorresponding author: Tel: 33-5-5655-6490; fax: 33-5-5655-6030.

Received 27 March 2006 ,Revised 3 July 2006 ,Accepted 3 July 2006.

References 

  1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359
  2. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome (The French D.E.S.I.R. study). Diabetes Metab. 2003;29:526–532
  3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689
  5. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366:1059–1062
  6. National Heart, Lung, and Blood Institute (Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)). Bethesda, MD: NIH; 2001;NIH Publication No. 01-3670
  7. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10(suppl):S1–S10
  8. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588–636
  9. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes (A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)). J Am Coll Cardiol. 2001;38:2114–2130
  10. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486–494
  11. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292:1440–1446
  12. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol. 2003;92:50–54
  13. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L’Huillier I, et al Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005;165:1192–1198
  14. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–2749
  15. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women’s Ischemia Syndrome Evaluation. Circulation. 2004;109:714–721

PII: S0002-9149(06)01615-8

doi: 10.1016/j.amjcard.2006.07.025

American Journal of Cardiology
Volume 98, Issue 11 , Pages 1429-1434 , 1 December 2006

Article Tools

* Image Usage & Resolution